Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Felzartamab is an investigational therapeutic human monoclonal antibody directed against CD38.
nostr:note126taawpm7qvut2xqqg55wvnr78yrmhx68hh8susgj5yy2e972elqgn4asv